ENDOCYTE INC·4

Feb 8, 4:45 PM ET

Parker Katherine 4

4 · ENDOCYTE INC · Filed Feb 8, 2018

Insider Transaction Report

Form 4
Period: 2018-02-08
Parker Katherine
VP of Human Resources
Transactions
  • Award

    Common Stock

    2018-02-08+12,50077,120 total
  • Award

    Stock Option (right to buy)

    2018-02-08+25,00025,000 total
    Exercise: $3.01Exp: 2028-02-08Common Stock (25,000 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    1,200
Footnotes (3)
  • [F1]Represents restricted stock units that will vest and be paid 1/4 annually over a period of 4 years beginning on 2/8/19, in the form of one share of common stock for each restricted stock unit.
  • [F2]Includes 1511 shares acquired under the Endocyte, Inc. 2010 Employee Stock Purchase Plan on December 15, 2017.
  • [F3]Shares subject to the option vest 1/4 annually over a 4 year period beginning 2/8/19.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -